Safety and Efficacy Study of PRI-724 in Subjects With Advanced Myeloid Malignancies
Clinical trial NCT01606579 · COMPLETED
Trial details
- NCT number
- NCT01606579
- Sponsor
- Prism Pharma Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-07-01
- Primary completion
- 2016-12-30
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.